Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinoma

被引:111
作者
Akdogan, Bulent [1 ]
Dogan, Hasan Serkan [1 ]
Eskicorapci, Saadettin Yilmaz [1 ]
Sahin, Ahmet [1 ]
Erkan, Ilhan [1 ]
Ozen, Haluk [1 ]
机构
[1] Hacettepe Univ, Sch Med, Dept Urol, Ankara, Turkey
关键词
urinary tract; carcinoma; transitional cell; mortality;
D O I
10.1016/S0022-5347(06)00511-8
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Purpose: We studied prognostic factors for 5-year disease specific and recurrence-free survival in patients treated for upper urinary tract transitional cell carcinoma. Materials and Methods: Since July 1987, 72 patients with a mean age of 58.9 years have undergone nephroureterectomy with bladder cuff excision. Median followup was 62.2 months (range 6 to 192). Patient age, sex, detection duration and mode, bladder tumor history, smoking habit, stone disease history, and tumor stage, grade and location were evaluated as prognostic factors. Results: Overall 5-year disease specific and recurrence-free survival rates were 74.9% and 67.8%, respectively. Univariate analysis revealed anemia, positive bladder tumor history, T stage, grade and tumor location in the upper tract as significant prognostic factors. On multivariate analysis T stage, grade and tumor location in the urothelium were the only significant variables for the 5-year disease specific and recurrence-free survival rates. Conclusions: High tumor stage and grade, and ureteral location were significantly associated with worse disease specific and recurrence-free survival in patients with upper urinary tract transitional cell carcinoma. Our results may help define the patient groups that need adjuvant therapy and they may form a basis for further controlled studies.
引用
收藏
页码:48 / 52
页数:5
相关论文
共 19 条
[1]
Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma [J].
Catto, JWF ;
Azzouzi, AR ;
Rehman, I ;
Feeley, KM ;
Cross, SS ;
Amira, N ;
Fromont, G ;
Sibony, M ;
Cussenot, O ;
Meuth, M ;
Hamdy, FC .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (13) :2903-2910
[2]
TUMORS OF THE UPPER URINARY-TRACT - 10 YEARS OF EXPERIENCE [J].
CHARBIT, L ;
GENDREAU, MC ;
MEE, S ;
CUKIER, J .
JOURNAL OF UROLOGY, 1991, 146 (05) :1243-1246
[3]
Ureteroscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys [J].
Chen, GL ;
Bagley, DH .
JOURNAL OF UROLOGY, 2000, 164 (04) :1173-1176
[4]
13-year experience with percutaneous management of upper tract transitional cell carcinoma [J].
Clark, PE ;
Streem, SB ;
Geisinger, MA .
JOURNAL OF UROLOGY, 1999, 161 (03) :772-775
[5]
Long-term follow-up of endoscopically treated upper urinary tract transitional cell carcinoma [J].
Elliott, DS ;
Blute, ML ;
Patterson, DE ;
Bergstralh, EJ ;
Segura, JW .
UROLOGY, 1996, 47 (06) :819-825
[6]
Incidence in Izmir in 1993-1994: first results from Izmir Cancer Registry [J].
Fidaner, C ;
Eser, SY ;
Parkin, DM .
EUROPEAN JOURNAL OF CANCER, 2001, 37 (01) :83-92
[7]
Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: A 30-year experience in 252 patients [J].
Hall, MC ;
Womack, S ;
Sagalowsky, AI ;
Carmody, T ;
Erickstad, MD ;
Roehrborn, CG .
UROLOGY, 1998, 52 (04) :594-601
[8]
TIME-RELATED RECURRENCE RATES IN PATIENTS WITH UPPER TRACT TRANSITIONAL CELL-CARCINOMA [J].
HATCH, TR ;
HEFTY, TR ;
BARRY, JM .
JOURNAL OF UROLOGY, 1988, 140 (01) :40-41
[9]
The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract [J].
Kang, CH ;
Yu, TJ ;
Hsieh, HH ;
Yang, JW ;
Shu, K ;
Huang, CC ;
Chiang, PH ;
Shiue, YL .
CANCER, 2003, 98 (08) :1620-1626
[10]
TRANSITIONAL CELL-CARCINOMA OF THE UPPER URINARY-TRACT - PROGNOSTIC VARIABLES AND POSTOPERATIVE RECURRENCES [J].
KROGH, J ;
KVIST, E ;
RYE, B .
BRITISH JOURNAL OF UROLOGY, 1991, 67 (01) :32-36